Literature DB >> 30825088

The evolution of professional societies in behavioral medicine.

Kenneth E Freedland1.   

Abstract

The Academy of Behavioral Medicine Research, the American Psychosomatic Society, the Society for Health Psychology, and the Society of Behavioral Medicine are the four largest behavioral medicine research organizations in North America. All four of these organizations have evolved over the past 40 years, in response to changing times and conditions. They have done so independently, and each one occupies a unique niche in the field of behavioral medicine. However, all four recognize the need for cooperation to address challenges of mutual concern and to capitalize on opportunities for behavioral medicine research to have a greater impact on preventive services and health care. The recent formation of the Behavioral Medicine Research Council (BMRC) is a prime example. As an autonomous joint committee of all four organizations, the BMRC will promote large, definitive, randomized controlled trials to address some of the highest-priority problems in behavioral medicine. This cooperative venture will help the entire field, along with the major behavioral medicine research organizations, continue to evolve in productive ways over the next 40 years.

Entities:  

Keywords:  Behavioral medicine; Multicenter studies as topic; Randomized controlled trials as topic; Societies, scientific

Mesh:

Year:  2019        PMID: 30825088      PMCID: PMC6938686          DOI: 10.1007/s10865-018-9946-3

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  11 in total

Review 1.  Consultation-liaison psychiatry and psychosomatic medicine: the company they keep.

Authors:  D R Lipsitt
Journal:  Psychosom Med       Date:  2001 Nov-Dec       Impact factor: 4.312

Review 2.  Sympathetic nervous system regulation of the tumour microenvironment.

Authors:  Steven W Cole; Archana S Nagaraja; Susan K Lutgendorf; Paige A Green; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

3.  From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases.

Authors:  Susan M Czajkowski; Lynda H Powell; Nancy Adler; Sylvie Naar-King; Kim D Reynolds; Christine M Hunter; Barbara Laraia; Deborah H Olster; Frank M Perna; Janey C Peterson; Elissa Epel; Josephine E Boyington; Mary E Charlson
Journal:  Health Psychol       Date:  2015-02-02       Impact factor: 4.267

Review 4.  The selection and design of control conditions for randomized controlled trials of psychological interventions.

Authors:  David C Mohr; Bonnie Spring; Kenneth E Freedland; Victoria Beckner; Patricia Arean; Steven D Hollon; Judith Ockene; Robert Kaplan
Journal:  Psychother Psychosom       Date:  2009-07-11       Impact factor: 17.659

5.  Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.

Authors:  Gitte Vrelits Sørensen; Patricia A Ganz; Steven W Cole; Lars A Pedersen; Henrik Toft Sørensen; Deirdre P Cronin-Fenton; Jens Peter Garne; Peer M Christiansen; Timothy L Lash; Thomas P Ahern
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

Review 6.  Behavioral and social sciences at the National Institutes of Health: Methods, measures, and data infrastructures as a scientific priority.

Authors:  William T Riley
Journal:  Health Psychol       Date:  2017-01       Impact factor: 4.267

7.  The epidemiologic transition. A theory of the epidemiology of population change.

Authors:  A R Omran
Journal:  Milbank Mem Fund Q       Date:  1971-10

8.  The multiphase optimization strategy for engineering effective tobacco use interventions.

Authors:  Linda M Collins; Timothy B Baker; Robin J Mermelstein; Megan E Piper; Douglas E Jorenby; Stevens S Smith; Bruce A Christiansen; Tanya R Schlam; Jessica W Cook; Michael C Fiore
Journal:  Ann Behav Med       Date:  2011-04

9.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

10.  Stress management, leukocyte transcriptional changes and breast cancer recurrence in a randomized trial: An exploratory analysis.

Authors:  Michael H Antoni; Laura C Bouchard; Jamie M Jacobs; Suzanne C Lechner; Devika R Jutagir; Lisa M Gudenkauf; Charles S Carver; Susan Lutgendorf; Steven W Cole; Marc Lippman; Bonnie B Blomberg
Journal:  Psychoneuroendocrinology       Date:  2016-09-24       Impact factor: 4.905

View more
  1 in total

1.  Introduction to the special series-behavioral medicine at 40: origins, achievements, and future directions.

Authors:  John M Ruiz; Christopher R France
Journal:  J Behav Med       Date:  2019-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.